Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06254170Not ApplicableUnknown

Supplementation Performance And Exercise With Euterpe Edulis for Men's Enhancement

Role: lead

NCT05493410Not ApplicableCompleted

EFFECTS OF INSPIRATORY MUSCLE TRAINING IN POST-COVID-19 PATIENTS

Role: lead

NCT03943303Not ApplicableTerminated

Effects of Sand Treatment on Osteoarthritis

Role: lead

NCT03649828Not ApplicableCompleted

Kefir and Metabolic Syndrome

Role: lead

All 4 trials loaded